Authored by: Remco op den Kelder, Global President of Inizio Advisory
In this Q&A with pharmaphorum, Remco op den Kelder, our Global President of Inizio Advisory, shares his leadership journey and vision for the future of healthcare strategy. Reflecting on over 20 years at Putnam and now leading Inizio’s global advisory offering, Remco discusses the importance of purpose-driven teamwork, the thoughtful integration of AI, and navigating a rapidly evolving pharma landscape. His insights offer a glimpse into the values that shape Inizio Advisory’s work: collaboration, critical thinking, and a deep commitment to improving patient outcomes.
Read the full interview here: pharmaphorum.com
Jump to a slide with the slide dots.
Inside ASCO® 2025: What oncologists really want from booth strategy
Congress engagement is being redefined - driven by oncologists’ learning preferences, AI integration, sustainability mandates, and smart booth design.
Read moreHow smart spaces and real-time strategy transformed ASCO® 2025
From LED walls to real-time in-booth optimization, ASCO® 2025 uncovered how we should engage and evolve the congress experience.
Read moreThe science is shifting in oncology: Are you ready to evolve with it?
It’s been a few weeks since ASCO® 2025, but one moment from the podium still echoes in my mind - the possibility of curing metastatic cancer.
Read more